5-year follow-up of a sham-controlled trial of PCI for intermediate coronary lesions: quantitative flow ratio guidance vs angiography lowered major adverse cardiac events (17.5% vs 21.1%; HR 0.80), mostly within 2 years; all-cause death did not differ.
RCT
Zhang et al. Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: 5-Year Follow-Up From the FAVOR III China Randomized Trial